Cellbyte
ActiveAI Agents for Pharma Drug Launches
This company has previously operated under “Glocally”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.
Founders · 1
Co-founder & CEO of Cellbyte. We are building AI agents to accelerate the launch and commercialization of pharmaceutical drugs. Pivoted from Last Mile Logistics in 2023: previously co-founded and led Operations at Glocally (W22), where we offered a same-day parcel delivery service to e-commerce brands like H&M. Utilizing electric vehicles only, we surpassed 150K parcels with excellent reviews, and raised >$2M from top-tier Angels and VCs (YC, Trucks,...).
Related startups
The world's first AI-maximalist pharma company
The dynamic single-cell analysis company
